Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $18.1M |
| Sales growthchange from the year before | +99.4% |
| Gross marginshare of sales left after the direct cost of what it sells | -3.7% |
| Operating marginshare of sales left after running the business | -705.8% |
| Net marginshare of sales kept as profit | -802.0% |
| Free-cash-flow marginspare cash generated per $100 of sales | -662.0% |
| Return on invested capitalprofit made on each $100 put into the business | -762.8% |
| Return on equityprofit vs. shareholders' accounting value | -1097.2% |
| Change in share countnegative = the company is buying back its shares | +6.9% |
3 insiders sold $423K on the open market.
| Sinha SaurabhChief Financial Officer | SoldJul 27 | 6,830 shat $15.40 · $105K |
| Rezk MinaChief Technology Officer · Director | SoldJul 27 | 10,304 shat $15.40 · $159K |
| Dardashti Soroush SalehianChief Executive Officer · Director | SoldJul 27 | 10,304 shat $15.40 · $159K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy